MCPI Enters Oregon's Third Largest OMMP Market with New Retail Location
CARROLLTON, TX / ACCESSWIRE / March 4, 2015 / Med-Cannabis Pharma, Inc. (MCPI) continues the path to expansion and has begun the process of establishing a dispensary in Lane County Oregon. As of January 1, 2015, Lane County has the third most Oregon Medical Marijuana Program (OMMP) patient registrants per county. In order to capitalize on serving and marketing to such a large patient base, MCPI has entered into a retail space lease agreement for an operational Medical Marijuana Dispensary in Lane County.
MCPI has already begun the work and renovations necessary on the structure for the dispensary location, while actively completing and complying with the regulations set forth by the OMMP in order to acquire full accreditation and operating approval. The Company is confident that it will meet all zoning documentation, security requirements, and other measures required to receive a physical certificate of registration from the Oregon Health Authority. Once a certificate has been issued, the Lane County dispensary will be fully operational and ready to serve this large patient base.
The Company will continue to emphasize the branding of its dispensaries, as The Medication Station will become the name of the newest location and the second Med-Cannabis Pharma, Inc. dispensary bearing this title. Through greater exposure and familiarity with The Medication Station name, MCPI intends to garner a brand recognition among its customers for owning distinguished dispensaries that deliver the newest and highest quality products to its customers throughout Oregon.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. The Company does not undertake any duty nor does it intend to update the results of these forward-looking statements.